Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dengue virus Ab.IgG:Titr:Pt:Ser:Qn

Known as: Dengue virus Ac IgG [Titre] Sérum ; Numérique, Dengue virus IgG Ab [Titer] in Serum, Dengue virus Ac IgG:Titre:Ponctuel:Sérum:Numérique 
 
National Institutes of Health

Related topics

Related topics

8 relations
AntibodiesDengue VirusDengue virus AbImmunoglobulin G
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Modeling the Heterogeneity of Dengue Transmission in a City
Dengue fever is one of the most important vector-borne diseases in the world, and modeling its transmission dynamics allows for… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2018
2018
Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1)
BackgroundDengue, caused by one of the four serologically distinct dengue viruses (DENV-1 to − 4), is a mosquito-borne disease of… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
2016
2016
Molecular and serological techniques to detect co-circulation of DENV, ZIKV and CHIKV in suspected dengue-like syndrome patients.
BACKGROUND Arboviruses are important emerging viruses worldwide. The signs and symptoms of Zika virus (ZIKV) infection are… Expand
2015
2015
An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques
The immunogenicity and protective efficacy of a candidate tetravalent dengue virus purified inactivated vaccine (TDENV PIV… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
2013
2013
Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity.
Sylvatic dengue viruses (DENV) are both evolutionarily and ecologically distinct from human DENV and are maintained in an… Expand
Highly Cited
2012
Highly Cited
2012
Electrochemical impedance spectroscopy characterization of nanoporous alumina dengue virus biosensor.
The Faradaic electrochemical impedance technique is employed to characterize the impedance change of a nanoporous alumina… Expand
2011
2011
Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic.
BACKGROUND Because infection with any of the 4 Dengue virus serotypes may elicit both protective neutralizing antibodies and… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2011
Highly Cited
2011
Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines.
A recombinant live attenuated tetravalent dengue vaccine (TDV) is safe and immunogenic in adults and children in dengue-naïve… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Highly Cited
2006
Highly Cited
2006
rDEN2/4Δ30(ME), a Live Attenuated Chimeric Dengue Serotype 2 Vaccine, is Safe and Highly Immunogenic in Healthy Dengue-Naïve Adults
rDEN2/4Δ30(ME) is an attenuated chimeric dengue virus in which the prM and E structural proteins of the DEN4 candidate vaccine… Expand
Highly Cited
2000
Highly Cited
2000
Live attenuated tetravalent dengue vaccine.
The development of a live attenuated tetravalent dengue vaccine is currently the best strategy to obtain a vaccine against dengue… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE